Take a closer look at Comecer’s automatic compounding system, PHARMODUCT. An innovative robotic system for antiblastic drug compounding, PHARMODUCT increases the efficiency of the oncology process. Designed to guide pharmacists in a step-by-step format, it makes methodical applications, quantity and production times simple with a controlled process that leverages smart automation.
Simplifying the antineoplastic compounding process
In chemotherapy workflow, PHARMODUCT introduces more operation and cost efficiency by simplifying the antineoplastic compounding process and reducing clinical risks for patients, while increasing safety for operators. This is the only medical device on the market for oncology compounding that guarantees the total sterility of the preparation chamber.